A Study of Lanadelumab in Teenagers and Adults to Prevent Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH)
Clinical trial NCT04206605 · COMPLETED
Trial details
- NCT number
- NCT04206605
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-04
- Primary completion
- 2022-10-20
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.